<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8135038</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">33991855</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">8135038</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pii">S2213-1582(21)00132-7</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.nicl.2021.102688</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">102688</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Demographic and Clinical Characteristics.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0005"><label>Table 1</label><caption><p>Demographic and Clinical Characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>Schizophrenia Group (n = 23)</th><th>Healthy Control Group (n = 29)</th><th>Statistic (t, F, or (χ<sup>2</sup>)</th><th>P-value)</th></tr></thead><tbody><tr><td>Age, Mean (SD)</td><td>37.0 (13.5)</td><td>41.6 (13.5)</td><td align="char">1.23</td><td align="char">0.23</td></tr><tr><td>Male/Female</td><td>16/7</td><td>15/14</td><td align="char">1.72</td><td align="char">0.15</td></tr><tr><td>BPRS Total, Mean (SD)</td><td>40.2 (10.6)</td><td>–</td><td align="char">–</td><td align="char">–</td></tr><tr><td>CPZ equivalent dose, Mean (SD)</td><td>583.8 (722.4)</td><td>–</td><td align="char">–</td><td align="char">–</td></tr><tr><td>Duration of Illness, Mean (SD)*</td><td>14.9 (15.6)</td><td>–</td><td align="char">–</td><td align="char">–</td></tr><tr><td>RMT, Mean (SD)</td><td>47.4 (8.5)</td><td>47.4 (6.5)</td><td align="char">0.02</td><td align="char">0.99</td></tr><tr><td>SICI, Mean (SD)</td><td>0.38 (0.28)</td><td>0.25 (0.16)</td><td align="char">−2.1</td><td align="char">0.04</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: BPRS = Brief Psychiatric Rating Scale; CPZ = chlorpromazine; RMT = resting motor threshold; SICI = short-interval intracortical inhibition; *Duration of illness was calculated as the participant’s present age minus the approximate age of persistent psychotic symptoms.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and Clinical Characteristics.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>Schizophrenia Group (n = 23)</th><th>Healthy Control Group (n = 29)</th><th>Statistic (t, F, or (χ2)</th><th>P-value)</th></tr></thead><tbody><tr><td>Age, Mean (SD)</td><td>37.0 (13.5)</td><td>41.6 (13.5)</td><td align="char">1.23</td><td align="char">0.23</td></tr><tr><td>Male/Female</td><td>16/7</td><td>15/14</td><td align="char">1.72</td><td align="char">0.15</td></tr><tr><td>BPRS Total, Mean (SD)</td><td>40.2 (10.6)</td><td>–</td><td align="char">–</td><td align="char">–</td></tr><tr><td>CPZ equivalent dose, Mean (SD)</td><td>583.8 (722.4)</td><td>–</td><td align="char">–</td><td align="char">–</td></tr><tr><td>Duration of Illness, Mean (SD)*</td><td>14.9 (15.6)</td><td>–</td><td align="char">–</td><td align="char">–</td></tr><tr><td>RMT, Mean (SD)</td><td>47.4 (8.5)</td><td>47.4 (6.5)</td><td align="char">0.02</td><td align="char">0.99</td></tr><tr><td>SICI, Mean (SD)</td><td>0.38 (0.28)</td><td>0.25 (0.16)</td><td align="char">−2.1</td><td align="char">0.04</td></tr></tbody></table></div>Abbreviations: BPRS = Brief Psychiatric Rating Scale; CPZ = chlorpromazine; RMT = resting motor threshold; SICI = short-interval intracortical inhibition; *Duration of illness was calculated as the participant’s present age minus the approximate age of persistent psychotic symptoms.</transformed-table></extracted-table><extracted-table><table-id>t0010</table-id><table-label>Table 2</table-label><table-caption/><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0010"><label>Table 2</label><table frame="hsides" rules="groups"><thead><tr><th>Model<hr/></th><th>Mediator (M)<hr/></th><th>Independent Predictor (X)<hr/></th><th>Outcome (Y)<hr/></th><th colspan="2">Sobel Test<hr/></th><th colspan="4">Permutation-Based Results<hr/></th></tr><tr><th/><th/><th/><th/><th>Test stat</th><th>p-value</th><th>Effect</th><th>Std Error</th><th>Lower CI</th><th>Upper CI</th></tr></thead><tbody><tr><td>1</td><td>ReHo rt insula</td><td>insula-motor FC</td><td>SICI</td><td align="char">0.11</td><td align="char">0.91</td><td align="char">0.442</td><td align="char">0.413</td><td>−0.864</td><td align="char">0.787</td></tr><tr><td>2</td><td>ReHo rt insula</td><td>insula-basal ganglia FC</td><td>SICI</td><td align="char">−0.53</td><td align="char">0.60</td><td align="char">−0.175</td><td align="char">0.339</td><td>−0.880</td><td align="char">0.532</td></tr><tr><td>3</td><td>ReHo rt insula</td><td>insula-STG FC</td><td>SICI</td><td align="char">−0.74</td><td align="char">0.46</td><td align="char">−0.211</td><td align="char">0.235</td><td>−0.749</td><td align="char">0.200</td></tr><tr><td>4*</td><td>Insula-motor FC</td><td>ReHo rt insula</td><td>SICI</td><td align="char">−3.04</td><td align="char">0.002</td><td align="char">−2.96</td><td align="char">0.893</td><td>−4.885</td><td align="char">−1.284</td></tr><tr><td>5</td><td>Insula-basal ganglia FC</td><td>ReHo rt insula</td><td>SICI</td><td align="char">−2.63</td><td align="char">0.009</td><td align="char">−2.505</td><td align="char">0.974</td><td>−4.736</td><td align="char">−0.817</td></tr><tr><td>6</td><td>Insula-STG FC</td><td>ReHo rt insula</td><td>SICI</td><td align="char">−2.47</td><td align="char">0.014</td><td align="char">−2.207</td><td align="char">0.952</td><td>−4.723</td><td align="char">−0.752</td></tr></tbody></table><table-wrap-foot><fn><p>*significant after Bonferroni correction for six tests (p = 0.05/6 = 0.0083).</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Model</th><th>Mediator (M)</th><th>Independent Predictor (X)</th><th>Outcome (Y)</th><th colspan="2">Sobel Test</th><th colspan="4">Permutation-Based Results</th></tr><tr><th/><th/><th/><th/><th>Test stat</th><th>p-value</th><th>Effect</th><th>Std Error</th><th>Lower CI</th><th>Upper CI</th></tr></thead><tbody><tr><td>1</td><td>ReHo rt insula</td><td>insula-motor FC</td><td>SICI</td><td align="char">0.11</td><td align="char">0.91</td><td align="char">0.442</td><td align="char">0.413</td><td>−0.864</td><td align="char">0.787</td></tr><tr><td>2</td><td>ReHo rt insula</td><td>insula-basal ganglia FC</td><td>SICI</td><td align="char">−0.53</td><td align="char">0.60</td><td align="char">−0.175</td><td align="char">0.339</td><td>−0.880</td><td align="char">0.532</td></tr><tr><td>3</td><td>ReHo rt insula</td><td>insula-STG FC</td><td>SICI</td><td align="char">−0.74</td><td align="char">0.46</td><td align="char">−0.211</td><td align="char">0.235</td><td>−0.749</td><td align="char">0.200</td></tr><tr><td>4*</td><td>Insula-motor FC</td><td>ReHo rt insula</td><td>SICI</td><td align="char">−3.04</td><td align="char">0.002</td><td align="char">−2.96</td><td align="char">0.893</td><td>−4.885</td><td align="char">−1.284</td></tr><tr><td>5</td><td>Insula-basal ganglia FC</td><td>ReHo rt insula</td><td>SICI</td><td align="char">−2.63</td><td align="char">0.009</td><td align="char">−2.505</td><td align="char">0.974</td><td>−4.736</td><td align="char">−0.817</td></tr><tr><td>6</td><td>Insula-STG FC</td><td>ReHo rt insula</td><td>SICI</td><td align="char">−2.47</td><td align="char">0.014</td><td align="char">−2.207</td><td align="char">0.952</td><td>−4.723</td><td align="char">−0.752</td></tr></tbody></table></div>*significant after Bonferroni correction for six tests (p = 0.05/6 = 0.0083).</transformed-table></extracted-table></extracted-tables-set>